Stock Market News4 hours Moderna Gets $590 Million of Federal Funding For Influenza Vaccines The Wall Street Journal
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said
XThe package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said
X